
The global Continuous Glucose Monitoring Systems market size is predicted to grow from US$ 6544 million in 2025 to US$ 20920 million in 2031; it is expected to grow at a CAGR of 21.4% from 2025 to 2031.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
The “Continuous Glucose Monitoring Systems Industry Forecast” looks at past sales and reviews total world Continuous Glucose Monitoring Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Continuous Glucose Monitoring Systems sales for 2025 through 2031. With Continuous Glucose Monitoring Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Continuous Glucose Monitoring Systems industry.
This Insight Report provides a comprehensive analysis of the global Continuous Glucose Monitoring Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Continuous Glucose Monitoring Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Continuous Glucose Monitoring Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Continuous Glucose Monitoring Systems and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Continuous Glucose Monitoring Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Glucose Monitoring Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wearable
Implantable
Segmentation by End Users:
Child
Adult
Elderly
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Continuous Glucose Monitoring Systems market?
What factors are driving Continuous Glucose Monitoring Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Continuous Glucose Monitoring Systems market opportunities vary by end market size?
How does Continuous Glucose Monitoring Systems break out by Type, by End Users?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Continuous Glucose Monitoring Systems Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Continuous Glucose Monitoring Systems by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Continuous Glucose Monitoring Systems by Country/Region, 2020, 2024 & 2031
2.2 Continuous Glucose Monitoring Systems Segment by Type
2.2.1 Wearable
2.2.2 Implantable
2.3 Continuous Glucose Monitoring Systems Sales by Type
2.3.1 Global Continuous Glucose Monitoring Systems Sales Market Share by Type (2020-2025)
2.3.2 Global Continuous Glucose Monitoring Systems Revenue and Market Share by Type (2020-2025)
2.3.3 Global Continuous Glucose Monitoring Systems Sale Price by Type (2020-2025)
2.4 Continuous Glucose Monitoring Systems Segment by End Users
2.4.1 Child
2.4.2 Adult
2.4.3 Elderly
2.5 Continuous Glucose Monitoring Systems Sales by End Users
2.5.1 Global Continuous Glucose Monitoring Systems Sale Market Share by End Users (2020-2025)
2.5.2 Global Continuous Glucose Monitoring Systems Revenue and Market Share by End Users (2020-2025)
2.5.3 Global Continuous Glucose Monitoring Systems Sale Price by End Users (2020-2025)
3 Global by Company
3.1 Global Continuous Glucose Monitoring Systems Breakdown Data by Company
3.1.1 Global Continuous Glucose Monitoring Systems Annual Sales by Company (2020-2025)
3.1.2 Global Continuous Glucose Monitoring Systems Sales Market Share by Company (2020-2025)
3.2 Global Continuous Glucose Monitoring Systems Annual Revenue by Company (2020-2025)
3.2.1 Global Continuous Glucose Monitoring Systems Revenue by Company (2020-2025)
3.2.2 Global Continuous Glucose Monitoring Systems Revenue Market Share by Company (2020-2025)
3.3 Global Continuous Glucose Monitoring Systems Sale Price by Company
3.4 Key Manufacturers Continuous Glucose Monitoring Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Continuous Glucose Monitoring Systems Product Location Distribution
3.4.2 Players Continuous Glucose Monitoring Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Continuous Glucose Monitoring Systems by Geographic Region
4.1 World Historic Continuous Glucose Monitoring Systems Market Size by Geographic Region (2020-2025)
4.1.1 Global Continuous Glucose Monitoring Systems Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Continuous Glucose Monitoring Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Continuous Glucose Monitoring Systems Market Size by Country/Region (2020-2025)
4.2.1 Global Continuous Glucose Monitoring Systems Annual Sales by Country/Region (2020-2025)
4.2.2 Global Continuous Glucose Monitoring Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Continuous Glucose Monitoring Systems Sales Growth
4.4 APAC Continuous Glucose Monitoring Systems Sales Growth
4.5 Europe Continuous Glucose Monitoring Systems Sales Growth
4.6 Middle East & Africa Continuous Glucose Monitoring Systems Sales Growth
5 Americas
5.1 Americas Continuous Glucose Monitoring Systems Sales by Country
5.1.1 Americas Continuous Glucose Monitoring Systems Sales by Country (2020-2025)
5.1.2 Americas Continuous Glucose Monitoring Systems Revenue by Country (2020-2025)
5.2 Americas Continuous Glucose Monitoring Systems Sales by Type (2020-2025)
5.3 Americas Continuous Glucose Monitoring Systems Sales by End Users (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Continuous Glucose Monitoring Systems Sales by Region
6.1.1 APAC Continuous Glucose Monitoring Systems Sales by Region (2020-2025)
6.1.2 APAC Continuous Glucose Monitoring Systems Revenue by Region (2020-2025)
6.2 APAC Continuous Glucose Monitoring Systems Sales by Type (2020-2025)
6.3 APAC Continuous Glucose Monitoring Systems Sales by End Users (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Continuous Glucose Monitoring Systems by Country
7.1.1 Europe Continuous Glucose Monitoring Systems Sales by Country (2020-2025)
7.1.2 Europe Continuous Glucose Monitoring Systems Revenue by Country (2020-2025)
7.2 Europe Continuous Glucose Monitoring Systems Sales by Type (2020-2025)
7.3 Europe Continuous Glucose Monitoring Systems Sales by End Users (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Continuous Glucose Monitoring Systems by Country
8.1.1 Middle East & Africa Continuous Glucose Monitoring Systems Sales by Country (2020-2025)
8.1.2 Middle East & Africa Continuous Glucose Monitoring Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Continuous Glucose Monitoring Systems Sales by Type (2020-2025)
8.3 Middle East & Africa Continuous Glucose Monitoring Systems Sales by End Users (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Continuous Glucose Monitoring Systems
10.3 Manufacturing Process Analysis of Continuous Glucose Monitoring Systems
10.4 Industry Chain Structure of Continuous Glucose Monitoring Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Continuous Glucose Monitoring Systems Distributors
11.3 Continuous Glucose Monitoring Systems Customer
12 World Forecast Review for Continuous Glucose Monitoring Systems by Geographic Region
12.1 Global Continuous Glucose Monitoring Systems Market Size Forecast by Region
12.1.1 Global Continuous Glucose Monitoring Systems Forecast by Region (2026-2031)
12.1.2 Global Continuous Glucose Monitoring Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Continuous Glucose Monitoring Systems Forecast by Type (2026-2031)
12.7 Global Continuous Glucose Monitoring Systems Forecast by End Users (2026-2031)
13 Key Players Analysis
13.1 Dexcom
13.1.1 Dexcom Company Information
13.1.2 Dexcom Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.1.3 Dexcom Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Dexcom Main Business Overview
13.1.5 Dexcom Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.2.3 Abbott Laboratories Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.3.3 Medtronic Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Senseonics Holdings
13.4.1 Senseonics Holdings Company Information
13.4.2 Senseonics Holdings Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.4.3 Senseonics Holdings Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Senseonics Holdings Main Business Overview
13.4.5 Senseonics Holdings Latest Developments
13.5 GlySens Incorporated
13.5.1 GlySens Incorporated Company Information
13.5.2 GlySens Incorporated Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.5.3 GlySens Incorporated Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GlySens Incorporated Main Business Overview
13.5.5 GlySens Incorporated Latest Developments
13.6 Meiqi Medical Equipment
13.6.1 Meiqi Medical Equipment Company Information
13.6.2 Meiqi Medical Equipment Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Meiqi Medical Equipment Main Business Overview
13.6.5 Meiqi Medical Equipment Latest Developments
13.7 San Meditech
13.7.1 San Meditech Company Information
13.7.2 San Meditech Continuous Glucose Monitoring Systems Product Portfolios and Specifications
13.7.3 San Meditech Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 San Meditech Main Business Overview
13.7.5 San Meditech Latest Developments
14 Research Findings and Conclusion
*If Applicable.
